Delineation of commonly deleted chromosomal regions in meningiomas by high-density single nucleotide polymorphism genotyping arrays

被引:18
作者
Dolores Tabernero, Maria [1 ,2 ,3 ,4 ]
Maillo, Angel [5 ]
Belen Nieto, Ana [3 ,4 ,6 ]
Diez-Tascon, Cristina [7 ]
Lara, Monica [5 ]
Sousa, Pablo [5 ]
Otero, Alvaro [5 ]
Castrillo, Abel [5 ]
del Carmen Patino-Alonso, Maria [6 ]
Espinosa, Ana [5 ]
Mackintosh, Carlos [3 ,4 ]
de Alava, Enrique [3 ,4 ]
Orfao, Alberto [3 ,4 ]
机构
[1] Univ Hosp Salamanca, Res Unit, Salamanca 58182, Spain
[2] IECSCYL, Soria, Spain
[3] Univ Salamanca, Dept Med, E-37008 Salamanca, Spain
[4] Univ Salamanca, Canc Res Ctr CIC IBMCC CSIC USAL, E-37008 Salamanca, Spain
[5] Univ Hosp Salamanca, Neurosurg Serv, Salamanca 58182, Spain
[6] Univ Salamanca, Dept Stat, E-37008 Salamanca, Spain
[7] Complejo Asistencial Leon, Dept Pathol, Leon, Spain
关键词
TUMOR PROGRESSION; BREAST-CANCER; EXPRESSION; AMPLIFICATION; GENE; P53; HETEROZYGOSITY; TRANSFORMATION; CYTOGENETICS; RECURRENCE;
D O I
10.1002/gcc.21948
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Despite recent advances in the identification of the cytogenetic profiles of meningiomas, a significant group of tumors still show normal karyotypes or few chromosomal changes. The authors analyzed the cytogenetic profile of 50 meningiomas using fluorescence in situ hybridization and high-density (500 K) single nucleotide polymorphism (SNP) arrays. Our results confirm that del(22q) (52%) and del(1p) (16%) (common deleted regions: 22q11.21-22q13.3. and 1p31.2-p36.33) are the most frequent alterations. Additionally, recurrent monosomy 14 (8%), del(6q) (10%), del(7p) (10%), and del(19q) (4%) were observed, while copy number patterns consistent with recurrent chromosomal gains, gene amplification, and copy number neutral loss of heterozygosity (cnLOH) were either absent or rare. Based on their overall SNP profiles, meningiomas could be classified into: (i) diploid cases, (ii) meningiomas with a single chromosomal change [e.g., monosomy 22/del(22q)] and (iii) tumors with =2 altered chromosomes. In summary, our results confirm and extend on previous observations showing that the most recurrent chromosomal abnormalities in meningiomas correspond to chromosome losses localized in chromosomes 1, 22 and less frequently in chromosomes 6, 7, 14, and 19, while chromosomal gains and cnLOH are restricted to a small proportion of cases. Finally, a set of cancer-associated candidate genes associated with the TP53, MYC, CASP3, HDAC1, and TERT signaling pathways was identified, in cases with coexisting monosomy 14 and del(1p). (c) 2012 Wiley Periodicals, Inc.
引用
收藏
页码:606 / 617
页数:12
相关论文
共 38 条
[1]   Emerging Paradigms in Cancer Genetics: Some Important Findings from High-Density Single Nucleotide Polymorphism Array Studies [J].
Bacolod, Manny D. ;
Schemmann, Gunter S. ;
Giardina, Sarah F. ;
Paty, Philip ;
Notterman, Daniel A. ;
Barany, Francis .
CANCER RESEARCH, 2009, 69 (03) :723-727
[2]   Array-based comparative genomic hybridization of mapped BAC DNA clones to screen for chromosome 14 copy number abnormalities in meningiomas [J].
Belen Espinosa, Ana ;
Mackintosh, Carlos ;
Maillo, Angel ;
Gutierrez, Laura ;
Sousa, Pablo ;
Merino, Marta ;
Ortiz, Javier ;
de Alava, Enrique ;
Orfao, Alberto ;
Dolores Tabernero, Maria .
EUROPEAN JOURNAL OF HUMAN GENETICS, 2008, 16 (12) :1450-1458
[3]   CAMK1D amplification implicated in epithelial-mesenchymal transition in basal-like breast cancer [J].
Bergamaschi, Anna ;
Kim, Young H. ;
Kwei, Kevin A. ;
Choi, Yoon La ;
Bocanegra, Melanie ;
Langerod, Anita ;
Han, Wonshik ;
Noh, Dony-Young ;
Huntsman, David G. ;
Jeffrey, Stefanie S. ;
Borresen-Dale, Anne-Lise ;
Pollack, Jonathan R. .
MOLECULAR ONCOLOGY, 2008, 2 (04) :327-339
[4]   MYC amplification and TERT expression in breast tumor progression [J].
Bodvarsdottir, Sigridur K. ;
Steinarsdottir, Margret ;
Hilmarsdottir, Holmfridur ;
Jonasson, Jon G. ;
Eyfjord, Jorunn E. .
CANCER GENETICS AND CYTOGENETICS, 2007, 176 (02) :93-99
[5]   Negative Regulation of β4 Integrin Transcription by Homeodomain-Interacting Protein Kinase 2 and p53 Impairs Tumor Progression [J].
Bon, Giulia ;
Di Carlo, Selene E. ;
Folgiero, Valentina ;
Avetrani, Paolo ;
Lazzari, Chiara ;
D'Orazi, Gabriella ;
Brizzi, Maria Felice ;
Sacchi, Ada ;
Soddu, Silvia ;
Blandino, Giovanni ;
Mottolese, Marcella ;
Falcioni, Rita .
CANCER RESEARCH, 2009, 69 (14) :5978-5986
[6]   A full-coverage, high-resolution human chromosome 22 genomic microarray for clinical and research applications [J].
Buckley, PG ;
Mantripragada, KK ;
Benetkiewicz, M ;
Tapia-Páez, I ;
de Ståhl, TD ;
Rosenquist, M ;
Ali, H ;
Jarbo, C ;
de Bustos, C ;
Hirvelä, C ;
Wilén, BS ;
Fransson, I ;
Thyr, C ;
Johnsson, BI ;
Bruder, CEG ;
Menzel, U ;
Hergersberg, M ;
Mandahl, N ;
Blennow, E ;
Wedell, A ;
Beare, DM ;
Collins, JE ;
Dunham, I ;
Albertson, D ;
Pinkel, D ;
Bastian, BC ;
Faruqi, AF ;
Lasken, RS ;
Ichimura, K ;
Collins, VP ;
Dumanski, JP .
HUMAN MOLECULAR GENETICS, 2002, 11 (25) :3221-3229
[7]   Telomeres, telomerase, and myc.: An update [J].
Cerni, C .
MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH, 2000, 462 (01) :31-47
[8]   CHEK2 Mutations Affecting Kinase Activity Together With Mutations in TP53 Indicate a Functional Pathway Associated with Resistance to Epirubicin in Primary Breast Cancer [J].
Chrisanthar, Ranjan ;
Knappskog, Stian ;
Lokkevik, Erik ;
Anker, Gun ;
Ostenstad, Bjorn ;
Lundgren, Steinar ;
Berge, Elisabet O. ;
Risberg, Terje ;
Mjaaland, Ingvil ;
Maehle, Lovise ;
Engebretsen, Lars Fredrik ;
Lillehaug, Johan Richard ;
Lonning, Per Eystein .
PLOS ONE, 2008, 3 (08)
[9]   Gene Expression Profiles of Meningiomas are Associated with Tumor Cytogenetics and Patient Outcome [J].
Dolores Tabernero, Maria ;
Maillo, Angel ;
Gil-Bellosta, Carlos J. ;
Castrillo, Abel ;
Sousa, Pablo ;
Merino, Marta ;
Orfao, Alberto .
BRAIN PATHOLOGY, 2009, 19 (03) :409-420
[10]   Genomic Profiling Reveals Alternative Genetic Pathways of Meningioma Malignant Progression Dependent on the Underlying NF2 Status [J].
Goutagny, Stephane ;
Yang, Hong Wei ;
Zucman-Rossi, Jessica ;
Chan, Jennifer ;
Dreyfuss, Jonathan M. ;
Park, Peter J. ;
Black, Peter M. ;
Giovannini, Marco ;
Carroll, Rona S. ;
Kalamarides, Michel .
CLINICAL CANCER RESEARCH, 2010, 16 (16) :4155-4164